1. Evaluation of antibody titers in COVID-19 patients with cerebral or pulmonary symptoms and mild symptoms
- Author
-
Nazanin Joudaki, Samireh Ghafouri, Kowsar Bavarsad, Farbod Farhadi, Marzieh Abbasi Nasab, Sara Afzalzadeh, Hamidreza Moradzadegan, and Roya Salehi Kahyesh
- Subjects
Antibodies ,COVID-19 ,SARS-CoV-2 ,Enzyme-linked immunosorbent assay ,IgM ,IgG ,Microbiology ,QR1-502 - Abstract
Background and Objectives: This study aimed to compare the production of antibodies in three different groups of patients with COVID-19. These groups included patients with pulmonary and cerebral symptoms, as well as those with mild symptoms. Materials and Methods: Blood samples were collected from 80 patients admitted to COVID-19-specific hospitals. The patients had various forms of SARS-CoV-2 disease, including those with pulmonary symptoms, brain involvement, and those with positive PCR test results but mild symptoms. The enzyme-linked immunosorbent assay (ELISA) technique was used to determine the levels of IgM and IgG antibody titers. Results: The levels of IgM and IgG antibody production differed significantly between groups of patients experiencing pulmonary symptoms and cerebral symptoms, with mild symptom patients also showing differences (P=0.0068), (P=0.0487), (P
- Published
- 2024
- Full Text
- View/download PDF